Runlin Gao

6.1k total citations · 3 hit papers
117 papers, 4.1k citations indexed

About

Runlin Gao is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Runlin Gao has authored 117 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Cardiology and Cardiovascular Medicine, 64 papers in Surgery and 26 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Runlin Gao's work include Coronary Interventions and Diagnostics (47 papers), Acute Myocardial Infarction Research (25 papers) and Cardiac Valve Diseases and Treatments (25 papers). Runlin Gao is often cited by papers focused on Coronary Interventions and Diagnostics (47 papers), Acute Myocardial Infarction Research (25 papers) and Cardiac Valve Diseases and Treatments (25 papers). Runlin Gao collaborates with scholars based in China, United States and United Kingdom. Runlin Gao's co-authors include Manlu Zhu, Yuejin Yang, Zengwu Wang, Zuo Chen, Congyi Zheng, Lan Shao, Ye Tian, Ying Dong, Jiali Wang and Linfeng Zhang and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Runlin Gao

107 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Status of Hypertension in China

2018 1.2k citations Runlin Gao et al. profile →
China cardiovascular diseases report 2018: an updated summary.

2020 311 citations Runlin Gao, Yuejin Yang et al. profile →
2023 Chinese guideline for lipid management

2023 81 citations Runlin Gao et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Runlin Gao China	28	2.0k	1.2k	504	447	435	117	4.1k
Pietro Scicchitano Italy	35	1.5k 0.7×	717 0.6×	397 0.8×	577 1.3×	278 0.6×	164	4.1k
Jeffrey Kluger United States	40	3.2k 1.6×	1.2k 1.0×	508 1.0×	471 1.1×	434 1.0×	285	5.9k
Dimitrios Tousoulis Greece	35	2.4k 1.1×	771 0.7×	558 1.1×	419 0.9×	298 0.7×	274	4.6k
Frank H. Wians United States	30	1.4k 0.7×	944 0.8×	579 1.1×	430 1.0×	482 1.1×	99	4.4k
Edward E. Herderick United States	28	1.2k 0.6×	877 0.8×	466 0.9×	317 0.7×	497 1.1×	53	3.7k
Marco Matteo Ciccone Italy	39	2.3k 1.1×	993 0.8×	558 1.1×	863 1.9×	423 1.0×	291	5.6k
Krzysztof J. Filipiak‬ Poland	37	3.0k 1.5×	1.3k 1.1×	958 1.9×	714 1.6×	376 0.9×	502	6.0k
Emil Hagström Sweden	37	1.4k 0.7×	824 0.7×	477 0.9×	229 0.5×	236 0.5×	119	4.1k
John Gregson United Kingdom	28	1.5k 0.7×	675 0.6×	192 0.4×	628 1.4×	449 1.0×	98	4.3k
Eung Ju Kim South Korea	33	2.1k 1.0×	1.8k 1.5×	549 1.1×	483 1.1×	590 1.4×	288	4.5k

Countries citing papers authored by Runlin Gao

Since Specialization

Citations

This map shows the geographic impact of Runlin Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runlin Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runlin Gao more than expected).

Fields of papers citing papers by Runlin Gao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Runlin Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runlin Gao. The network helps show where Runlin Gao may publish in the future.

Co-authorship network of co-authors of Runlin Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Runlin Gao. A scholar is included among the top collaborators of Runlin Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Runlin Gao. Runlin Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Power, David, Anton Camaj, Dean J. Kereiakes, et al.. (2025). Early and Late Outcomes With the Absorb Bioresorbable Vascular Scaffold. JACC: Cardiovascular Interventions. 18(1). 1–11. 4 indexed citations

Wang, Weiwei, Yunqing Ye, Zhe Li, et al.. (2024). Clinical Characteristics, Outcomes, and Risk Stratification of Combined Mitral and Tricuspid Regurgitation. JACC Asia. 5(3). 436–452.

Zhu, Pei, Xiaofang Tang, Yulong Li, et al.. (2023). Five-Year Prognostic Value of DAPT Score in Older Patients undergoing Percutaneous Coronary Intervention: A Large-Sample Study in the Real World. Journal of Atherosclerosis and Thrombosis. 30(8). 1057–1069. 2 indexed citations

Cui, Wen, Jun Zhang, Yuan Wu, et al.. (2023). Novel Platelet Function Analyzer 200 Predicts Blood Transfusion After Elective Cardiac Surgery in Patients Suspended on Dual Antiplatelet Therapy. Clinical and Applied Thrombosis/Hemostasis. 29. 2995369131–2995369131. 1 indexed citations

Ye, Yunqing, Zhe Li, Bin Zhang, et al.. (2023). Development and validation of a score predicting mortality for older patients with mitral regurgitation. Journal of Geriatric Cardiology. 20(8). 577–585.

Li, Yulong, Jiawen Li, Changdong Guan, et al.. (2022). Impact of Diabetes Mellitus on One-Year Clinical Outcomes in Patients Anticoagulated with Bivalirudin Undergoing Elective Percutaneous Coronary Intervention. Clinical and Applied Thrombosis/Hemostasis. 28. 2985294848–2985294848. 2 indexed citations

Wang, Haoyu, Bo Xu, Kefei Dou, et al.. (2021). Implications of Periprocedural Myocardial Biomarker Elevations and Commonly Used MI Definitions After Left Main PCI. JACC: Cardiovascular Interventions. 14(15). 1623–1634. 36 indexed citations

Cui, Jingang, Shubin Qiao, Lijian Gao, et al.. (2019). The Effective and Safe Way to Use Crusade Microcatheter-Facilitated Reverse Wire Technique to Solve Bifurcated Lesions with Markedly Angulated Target Vessel. Journal of Interventional Cardiology. 2019. 1–7. 2 indexed citations

Jia, Sida, Yi Yao, Yuejin Yang, et al.. (2019). TCTAP A-010 Long-term Outcomes After Left Main Coronary Artery Percutaneous Coronary Intervention in Patients Presenting with Acute Coronary Syndrome. Journal of the American College of Cardiology. 73(15). S6–S6.

10.

Xu, Jingjing, Ying Song, Ping Jiang, et al.. (2018). Effect of prior stroke on long‐term outcomes of percutaneous coronary interventions in Chinese patients: A large single‐center study. Catheterization and Cardiovascular Interventions. 93(2). E75–E80. 2 indexed citations

11.

Xu, Bo, Nicolas Bettinger, Yuejin Yang, et al.. (2015). TCT-484 Impact of Left Main Percutaneous Coronary Intervention Operator’s Experience and Volume on Outcomes after Left Main Percutaneous Coronary Intervention (PCI): Insight from a Cohort of 1,948 Patients. Journal of the American College of Cardiology. 66(15). B198–B198.

12.

Xu, Bo, Yelin Zhao, Yuejin Yang, et al.. (2014). Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: 12-month results from the TARGET II trial. Chinese Medical Journal. 127(6). 1027–1032. 11 indexed citations

13.

Zhang, Yao‐Jun, Runlin Gao, Bo Xu, Paul Cummins, & Patrick W. Serruys. (2014). Bioresorbable scaffolds for coronary artery disease: current status and future prospective. Chinese Medical Journal. 127(6). 1141–1148. 6 indexed citations

14.

Dong, Hui, Xiongjing Jiang, Meng Peng, et al.. (2014). Percutaneous Transluminal Angioplasty for Symptomatic Pulmonary Stenosis in Takayasu Arteritis. The Journal of Rheumatology. 41(9). 1856–1862. 17 indexed citations

15.

Wu, Chao, Hong Qiu, Lianjun Xu, et al.. (2013). Inhibitory effect of iron on in vitro proliferation of smooth muscle cells. Chinese Medical Journal. 126(19). 3728–3731. 2 indexed citations

16.

Xu, Bo, Runlin Gao, Jianan Wang, et al.. (2013). TCT-56 PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis - 9-Month Angiographic and 12-Month Clinical Results. Journal of the American College of Cardiology. 62(18). B18–B18. 1 indexed citations

17.

Jiang, Ping, Ying Song, Jingjing Xu, et al.. (2013). Two-year prognostic value of mean platelet volume in patients with diabetes and stable coronary artery disease undergoing elective percutaneous coronary intervention. Cardiology Journal. 26(2). 138–146. 11 indexed citations

18.

Han, Yaling, Lei Zhang, Huiliang Liu, et al.. (2012). A new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE study. EuroIntervention. 8(7). 815–822. 27 indexed citations

19.

Gao, Runlin, Jian Zhang, Xue-si Wu, et al.. (2010). A Phase II, Randomized, Double-Blind, Multicenter, Based on Standard Therapy, Placebo-Controlled Study of the Efficacy and Safety of Recombinant Human Neuregulin-1 in Patients With Chronic Heart Failure. Journal of the American College of Cardiology. 55(18). 1907–1914. 212 indexed citations

20.

Chen, Shao-Liang, Yves Louvard, & Runlin Gao. (2009). Perspective on Bifurcation PCI. Journal of Interventional Cardiology. 22(2). 99–109. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact